Kainos Evolve? to provide EMR solution to Saolta University Health Care Group

Date posted
6 July 2017
Reading time
4 Minutes

Kainos Evolve? to provide EMR solution to Saolta University Health Care Group

Pictured at the signing of the contract with Kainos Evolve are: Ann Cosgrove, Chief Operations Officer, Saolta; Seamus Butler, Delivery Director Acute Hospitals, HSE Office of CIOO; Paula Power, Medical Records Officer GUH; Chris Kane, General Manager, Galway University Hospitals; Anthony Dooher, Business Development Manager, Kainos; Martin Molloy IS Manager GUH; Dr Ramona Mcloughlin, Associate Clinical Director, Medicine, GUH and Vincent Jordan, HSE Office of CIO Belfast & London 6 July, 2017 Kainos Group plc (KNOS), a leading provider of digital services and platforms, announces that its healthcare division, Kainos Evolve, has signed a deal with the Health Service Executive of Ireland and Saolta University Health Care Group in Galway for the provision of the Kainos Evolve Electronic Medical Record (EMR) solution. The contract is for three years, with provision for a further two year extension. Evolve is the leading clinical document management platform in the UK, selected by 35 NHS Trusts and in use in 110 hospitals, covering notes and images for over 33 million patients. This new engagement with Saolta represents Kainos Evolve's first deal in Ireland. Evolve will be implemented in a phased approach across Saolta's entire 3,000-member clinical user base. The project will accommodate mobile access via Evolve's solution for iPad, management of incoming patient referrals and onward patient flow, clinical quality management and integration with imaging systems. By deploying these components, Kainos Evolve has the potential to transform the efficiency and effectiveness of care across the entire Saolta University Health Care Group and partner organisations. Brendan Mooney, CEO of Kainos Group, commented: 'I'm pleased to announce this first contract win for Kainos Evolve in Ireland. This is testament to the quality of our offerings and the investment that we have in our healthcare platforms in recent years. There is large addressable market for Evolve and we remain committed to enhancing our offering and making further in-roads in Ireland and across the UK.'